abstract |
The invention describes compounds represented by structural formula (I) wherein all variables are defined herein. In addition, the use of such compounds for the inhibition of a G-protein paired receptor described as a chemoattractant receptor-homologous molecule expressed in Th2 ("CRTH2") for the treatment of inflammatory disorders is described. |